Spyre Therapeutics Inc <SYRE.O>: Raymond James cuts target price to $114 from $121
SYRE•Related News
APi Group to join Jefferies Global Industrials Conference fireside chat
APG•
Venu director Thomas Finke acquires 30,000 common shares worth $57,600
VENU•
Asset manager Victory Capital strikes $7 billion deal for First Eagle Investments
VCTR•
e.l.f. Brands debuts consumer activation at Minnesota State Fair
ELF•
Senmiao Technology Changes Name To Valor Energy On August 18, 2026
AIHS•